Core Insights - The Procter & Gamble Company (PG) is a leading global consumer staples company with a market cap of approximately $352.7 billion, producing well-known brands such as Tide, Pampers, Gillette, and Olay [1] Performance Overview - PG shares have underperformed the broader market over the past 52 weeks, declining 9.3%, while the S&P 500 Index has gained 14.3%. However, in 2026, PG shares are up 5.9%, compared to a 1.4% rise in the S&P 500 [2][3] - PG has also lagged behind the State Street Consumer Staples Select Sector SPDR Fund (XLP), which rose 4.7% over the past 52 weeks and 7.5% year-to-date [3] Earnings Report - On January 22, PG reported Q2 earnings with net sales of $22.2 billion, reflecting a 1% year-over-year increase, while organic sales remained flat due to higher prices offsetting weaker volumes. EPS declined 5% to $1.78, primarily due to restructuring charges, but core EPS remained steady at $1.88. The company maintained its full-year guidance for sales and earnings growth despite margin pressures [5] Analyst Expectations - For the fiscal year ending in June 2026, analysts project PG's EPS to grow 2.2% year-over-year to $6.98. The company has a strong earnings surprise history, having met or beaten consensus estimates in the last four quarters. The consensus rating among 25 analysts is a "Moderate Buy," consisting of 10 "Strong Buy," 4 "Moderate Buy," and 11 "Hold" ratings [6] Analyst Ratings Update - Recently, TD Cowen analyst Robert Moskow downgraded PG from "Buy" to "Hold," while raising the price target to $156 from $150, indicating a 4% increase despite a more cautious outlook. The mean price target of $167.82 suggests a potential upside of 10.6%, while the highest price target of $181 implies a potential upside of 19.3% from the current price [7]
Procter & Gamble Stock: Is Wall Street Bullish or Bearish?